Association of plasma microRNA-16-5p and abdominal aortic calcification in maintenance hemodialysis patients

Qiaojing Liang1, Chen Fu2, Yingjie Liu1

  • 1Department of Nephrology, Faculty of Kidney Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Renal Failure
|July 25, 2024
PubMed

Insights

Lower microRNA-16-5p (miR-16-5p) levels are linked to increased vascular calcification in maintenance hemodialysis patients. This finding suggests miR-16-5p may be a potential risk factor for this common complication.

Area of Science:

  • Biomedical research
  • Molecular biology
  • Nephrology

Background:

  • Vascular calcification is a significant complication in maintenance hemodialysis (MHD) patients.
  • microRNA-16-5p (miR-16-5p) is implicated in vascular calcification pathogenesis.
  • The role of miR-16-5p in MHD patients with vascular calcification is not well understood.

Purpose of the Study:

  • To investigate the association between serum miR-16-5p expression and vascular calcification in MHD patients.
  • To determine if miR-16-5p levels can serve as a risk indicator for calcification in this population.

Main Methods:

  • Cross-sectional study of 132 MHD patients.
  • Assessment of vascular calcification using the Abdominal Aortic Calcification (AAC) score.
  • Quantification of serum miR-16-5p expression via quantitative real-time polymerase chain reaction (qRT-PCR).
  • Statistical analyses including correlation, linear, and logistic regression.

Main Results:

  • Vascular calcification was present in 59.80% of the studied MHD patients.
  • A decrease in miR-16-5p expression was significantly associated with higher AAC scores.
  • Lower miR-16-5p expression, reduced urea nitrogen, elevated white blood cell count, and longer dialysis vintage were risk factors for vascular calcification.
  • The miR-16-5p-based logistic regression model showed a high predictive value (AUC = 0.842).

Conclusions:

  • Serum miR-16-5p expression is independently associated with the degree of vascular calcification in MHD patients.
  • Low miR-16-5p expression is a potential risk factor for vascular calcification in MHD patients.
  • miR-16-5p may represent a novel biomarker for assessing calcification risk in MHD patients.